Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): Clinical Features, Treatment, and Outcome. a Single Institution Result of 145 Patients from the Middle East

被引：0
|
作者：
Akhtar, Saad
Al-Kofide, Amani
Bakshi, Nasir
Shamayel, Mohammed
Khafaga, Yasser
Al-Sweedan, Suleimman
Elhassan, Tusneem
Rauf, M. S.
Maghfoor, Irfan
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2794
引用
收藏
页数：3
相关论文
共 45 条
  • [31] Long-term outcome of patients with early-stage nodular lymphocyte-predominant hodgkin lymphoma (NLPHL) treated within the randomized HD7, HD10 and HD13 trials: An analysis from the German Hodgkin Study Group (GHSG)
    Eichenauer, D. A.
    Pluetschow, A.
    Fuchs, M.
    von Tresckow, B.
    Borchmann, P.
    Engert, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 142 - 142
  • [32] Early-Stage, Lymphocyte-Predominant Hodgkin's Lymphoma: Patient Outcomes From a Large, Single-Institution Series With Long Follow-Up
    Chen, Ronald C.
    Chin, Michael S.
    Ng, Andrea K.
    Feng, Yang
    Neuberg, Donna
    Silver, Barbara
    Pinkus, Geraldine S.
    Stevenson, Mary Ann
    Mauch, Peter M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (01) : 136 - 141
  • [33] Histopathological growth patterns in patients with advanced nodular lymphocyte-predominant Hodgkin lymphoma treated within the randomized HD18 study: a report from the German Hodgkin Study Group
    Eichenauer, Dennis A.
    Buhnen, Ina
    Kreissl, Stefanie
    Goergen, Helen
    Fuchs, Michael
    von Tresckow, Bastian
    Rosenwald, Andreas
    Klapper, Wolfram
    Hansmann, Martin-Leo
    Moller, Peter
    Bernd, Heinz-Wolfram
    Feller, Alfred C.
    Engert, Andreas
    Borchmann, Peter
    Hartmann, Sylvia
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 196 (01) : 99 - 104
  • [34] Nodular Lymphocyte Predominant Hodgkin Lymphoma: A Real-world Case Series of Consecutive Patients Treated by a Single Multidisciplinary Team in the East of England From 1999 to 2015
    Griffin, Jessica C.
    Sadullah, Shalal
    Igali, Lazlo
    Shah, Nimish K.
    Wimperis, Jennifer Z.
    Bowles, Kristian M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (12): : E75 - E78
  • [35] Nodular, Lymphocyte-Predominant Hodgkin Lymphoma A Long-Term Study and Analysis of Transformation to Diffuse Large B-Cell Lymphoma in a Cohort of 164 Patients From the Adult Lymphoma Study Group
    Biasoli, Irene
    Stamatoullas, Aspasia
    Meignin, Veronique
    Delmer, Alain
    Reman, Oumedaly
    Morschhauser, Franck
    Coiffier, Bertrand
    Bosly, Andre
    Divine, Marine
    Brice, Pauline
    CANCER, 2010, 116 (03) : 631 - 639
  • [36] Comparison of patients (Pts) characteristic and treatment outcomes in lymphocyte-predominant (LPHD) and classical Hodgkin's disease (cHD): A report from the German Hodgkin Lymphoma Study Group (GHSG).
    Nogova, L
    Reineke, T
    Josting, A
    Behringer, K
    Pfistner, B
    Diehl, V
    Engert, A
    BLOOD, 2004, 104 (11) : 368A - 369A
  • [37] Long-Term Follow-Up of Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma Treated in the HD7 to HD15 Trials: A Report From the German Hodgkin Study Group
    Eichenauer, Dennis A.
    Pluetschow, Annette
    Fuchs, Michael
    Sasse, Stephanie
    Baues, Christian
    Boell, Boris
    von Tresckow, Bastian
    Diehl, Volker
    Borchmann, Peter
    Engert, Andreas
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (07) : 698 - +
  • [38] Diffuse Large B-Cell Transformation in Nodular Lymphocyte Predominant Hodgkin Lymphoma: Incidence, Risk Factors and Outcomes After a Forty-Year Experience From a Single Institution
    Sirop, Saad J.
    Habermann, Thomas M.
    Macon, William R.
    Ristow, Kay M.
    Ansell, Stephen M.
    Colgan, Joseph P.
    Johnston, Patrick B.
    Inwards, David J.
    Markovic, Svetomir N.
    Micallef, Ivana N.
    Thompson, Carrie
    Porrata, Luis F.
    Martenson, James A., Jr.
    Cerhan, James R.
    Witzig, Thomas E.
    Nowakowski, Grzegorz S.
    BLOOD, 2012, 120 (21)
  • [39] NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA BEHAVES AS A DISTINCT CLINICAL ENTITY WITH GOOD OUTCOME: EVIDENCE FROM 14 YEAR FOLLOW-UP FROM THE WEST OF SCOTLAND CANCER NETWORK
    Farrell, K.
    Mckay, P.
    Leach, M.
    ANNALS OF ONCOLOGY, 2011, 22 : 181 - 181
  • [40] Nodular lymphocyte predominant Hodgkin lymphoma behaves as a distinct clinical entity with good outcome: evidence from 14-year follow-up in the West of Scotland Cancer Network
    Farrell, Katrina
    McKay, Pamela
    Leach, Mike
    LEUKEMIA & LYMPHOMA, 2011, 52 (10) : 1920 - 1928
12345